Signatur Biosciences

Developer of molecular diagnostic kits compatible with standard PCR equipment

placeNew York City, New York, United States calendar_todayFounded 2022 groups6 employees language signatur.bio

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 19 times.

YearFilings
20231
20251
20261

Social engagement

Social engagement: 2.8K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%

Recent activity

30 Apr 2026
Event
ESMO Breast Cancer 2026
6 Aug 2025
Event
IEEE Engineering Medicine and Biology Society 2025
Coming soon